"Perfect Storm" Of Issues Driving Firms To Mull Non-U.S. Growth - Survey
This article was originally published in The Gray Sheet
Executive Summary
Economic uncertainty, policy changes and regulatory frustration over the 510(k) process are pushing device companies to explore moving more operations outside of the U.S., according to an industry survey
You may also be interested in...
Senate Subcommittee Explores Innovation Strategy, With Device Emphasis
Device, investor and technology leaders told a U.S. Senate subcommittee on June 22 that they want a more thoughtful national strategy on innovation competitiveness - one that increases collaboration between industry and university researchers and reforms often confusing regulatory roadblocks
Gephardt-Led Group Steps Up Medical Innovation Lobbying Effort
An advocacy group headed by former U.S. House Majority Leader Dick Gephardt is launching a coordinated lobbying effort to improve federal policies impacting medical innovation, including calls to strengthen the R&D tax credit and make FDA oversight more predictable
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.